Skip to main content

Peer Review reports

From: Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol

Original Submission
12 Feb 2018 Submitted Original manuscript
15 Apr 2018 Author responded Author comments - Akihiko Takeuchi
Resubmission - Version 2
15 Apr 2018 Submitted Manuscript version 2
7 Jul 2018 Reviewed Reviewer Report - Pengfei Lei
18 Jul 2018 Reviewed Reviewer Report - Davide Maria Donati
10 Aug 2018 Author responded Author comments - Akihiko Takeuchi
Resubmission - Version 3
10 Aug 2018 Submitted Manuscript version 3
14 Nov 2018 Author responded Author comments - Akihiko Takeuchi
Resubmission - Version 4
14 Nov 2018 Submitted Manuscript version 4
28 Jan 2019 Author responded Author comments - Akihiko Takeuchi
Resubmission - Version 5
28 Jan 2019 Submitted Manuscript version 5
29 Jan 2019 Author responded Author comments - Akihiko Takeuchi
Resubmission - Version 6
29 Jan 2019 Submitted Manuscript version 6
Publishing
1 Feb 2019 Editorially accepted
9 Feb 2019 Article published 10.1186/s12891-019-2453-z

You can find further information about peer review here.

Back to article page